8102
-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Neuropsychiatric Disease and Treatment
(2,361,223) Views
Editor in Chief Dr Roger M Pinder
1176-6328
Erratum
Shapiro MA, Chang YL, Munson SK, et al.
Neuropsychiatric Disease and Treatment 2008, 4:319-319
04 March 2008
Review
Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
A Carlo Altamura, Jose M Goikolea
Neuropsychiatric Disease and Treatment 2008, 4:311-317
04 March 2008
Case report
First true initial ictal SPECT in partial epilepsy verified by electroencephalography
Jesús Pastor, Luis Domínguez-Gadea, Rafael G Sola, Virgilio Hernando, María Luisa Meilán, et al
Neuropsychiatric Disease and Treatment 2008, 4:305-309
04 March 2008
Case report
Normal pressure hydrocephalus co-existing with a second dementia disorder
Joseph Alisky
Neuropsychiatric Disease and Treatment 2008, 4:301-304
04 March 2008
Original Research
Effects of milnacipran on binge eating – a pilot study
Shun’ichi Noma, Teruhisa Uwatoko, Haruka Yamamoto, Takuji Hayashi
Neuropsychiatric Disease and Treatment 2008, 4:295-300
04 March 2008
Original Research
Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics
Takahiko Nagamine
Neuropsychiatric Disease and Treatment 2008, 4:289-294
04 March 2008
Original Research
White versus gray matter function as seen on neuropsychological testing following bone marrow transplant for acute leukemia in childhood
Fiona S Anderson, Alicia S Kunin-Batson, Joanna L Perkins, K Scott Baker
Neuropsychiatric Disease and Treatment 2008, 4:283-288
04 March 2008
Original Research
Preliminary effects of pagoclone, a partial GABAA agonist, on neuropsychological performance
Angela F Caveney, Bruno Giordani, George M Haig
Neuropsychiatric Disease and Treatment 2008, 4:277-282
04 March 2008
Original Research
Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
André Tadic, Dan Rujescu, Matthias J Müller, Ralf Kohnen, Hans H. Stassen, et al
Neuropsychiatric Disease and Treatment 2008, 4:269-276
04 March 2008
Original Research
The classification of chronic daily headache in French children and adolescents: A comparison between the second edition of the International Classification of Headache Disorders and Silberstein-Lipton criteria
Jean-Christophe Cuvellier, Frédéric Couttenier, Stéphane Auvin, Louis Vallée
Neuropsychiatric Disease and Treatment 2008, 4:263-267
11 May 2008
Original Research
Prevalence of eating disorders and eating attacks in narcolepsy
Norbert Dahmen, Julia Becht, Alice Engel, Monika Thommes, Peter Tonn
Neuropsychiatric Disease and Treatment 2008, 4:257-261
04 March 2008
Original Research
Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
Maurizio Pompili, Marco Innamorati, Michele Raja, Ilaria Falcone, Giuseppe Ducci, et al
Neuropsychiatric Disease and Treatment 2008, 4:247-255
04 March 2008
Original Research
Functional MRI evidence for language plasticity in adult epileptic patients: Preliminary results
Emilie Cousin, Monica Baciu, Cédric Pichat1, Philippe Kahane, Jean-François Le Bas
Neuropsychiatric Disease and Treatment 2008, 4:235-246
04 March 2008
Original Research
Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran
Naghmeh Mokhber, Carol J Lane, Mohamad R Azarpazhooh, Elham Salari, Reza Fayazi, et al
Neuropsychiatric Disease and Treatment 2008, 4:227-234
11 May 2008
Original Research
Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Javier Rejas-Gutiérrez, Milagrosa Blanca-Tamayo
Neuropsychiatric Disease and Treatment 2008, 4:219-226
04 March 2008
Original Research
Neurosteroids block the increase in intracellular calcium level induced by Alzheimer’s β-amyloid protein in long-term cultured rat hippocampal neurons
Midori Kato-Negishi, Masahiro Kawahara
Neuropsychiatric Disease and Treatment 2008, 4:209-218
04 March 2008
Original Research
Risperidone treatment for ADHD in children and adolescents with bipolar disorder
Joseph Biederman, Paul Hammerness, Robert Doyle, Gagan Joshi, Megan Aleardi, Eric Mick
Neuropsychiatric Disease and Treatment 2008, 4:203-207
04 March 2008
Original Research
The relationship between early life stress and microstructural integrity of the corpus callosum in a non-clinical population
Robert Paul, Lorrie Henry, Stuart M Grieve, Thomas J Guilmette, Raymond Niaura, et al
Neuropsychiatric Disease and Treatment 2008, 4:193-201
04 March 2008
Original Research
Resting and reactive frontal brain electrical activity (EEG) among a non-clinical sample of socially anxious adults: Does concurrent depressive mood matter?
Elliott A Beaton, Louis A Schmidt, Andrea R Ashbaugh, Diane L Santesso, Martin M Antony, Randi E McCabe
Neuropsychiatric Disease and Treatment 2008, 4:187-192
04 March 2008
Review
Treatment of adult ADHD: Is current knowledge useful to clinicians?
Terje Torgersen, Bjørn Gjervan, Kirsten Rasmussen
Neuropsychiatric Disease and Treatment 2008, 4:177-186
04 March 2008
Review
Adenylyl cyclase-cyclicAMP signaling in mood disorders: Role of the crucial phosphorylating enzyme protein kinase A
Yogesh Dwivedi, Ghanshyam N Pandey
Neuropsychiatric Disease and Treatment 2008, 4:161-176
04 March 2008
Review
Gait analysis in demented subjects: Interests and perspectives
Olivier Beauchet, Gilles Allali, Gilles Berrut, Caroline Hommet, Véronique Dubost, Frédéric Assal
Neuropsychiatric Disease and Treatment 2008, 4:155-160
04 March 2008
Review
Epidemiology and treatment of post-stroke depression
Stefano Paolucci
Neuropsychiatric Disease and Treatment 2008, 4:145-154
04 March 2008
Review
Social anxiety disorder: A review of environmental risk factors
Christina A Brook, Louis A Schmidt
Neuropsychiatric Disease and Treatment 2008, 4:123-143
04 March 2008
Review
Treatment of adults with attention-deficit/hyperactivity disorder
Dusan Kolar, Amanda Keller, Maria Golfinopoulos, Lucy Cumyn, Cassidy Syer, Lily Hechtman
Neuropsychiatric Disease and Treatment 2008, 4:107-121
04 March 2008
Review
Pharmacological management of panic disorder
Carlo Marchesi
Neuropsychiatric Disease and Treatment 2008, 4:93-106
04 March 2008
Review
Depression in Parkinson’s disease: Health risks, etiology, and treatment options
Pasquale G Frisina, Joan C Borod, Nancy S Foldi, Harriet R Tenenbaum
Neuropsychiatric Disease and Treatment 2008, 4:81-91
04 March 2008
Review
A review of ramelteon in the treatment of sleep disorders
David N Neubauer
Neuropsychiatric Disease and Treatment 2008, 4:69-79
04 March 2008
Review
Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
Jeffrey R Bishop, Mani N Pavuluri
Neuropsychiatric Disease and Treatment 2008, 4:55-68
04 March 2008
Review
Review of frovatriptan in the treatment of migraine
Leslie Kelman
Neuropsychiatric Disease and Treatment 2008, 4:49-54
04 March 2008
Review
Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
David J Brooks
Neuropsychiatric Disease and Treatment 2008, 4:39-47
04 March 2008
Review
Monotherapy for partial epilepsy: focus on levetiracetam
Antonio Gambardella, Angelo Labate, Eleonora Colosimo, Roberta Ambrosio, Aldo Quattrone
Neuropsychiatric Disease and Treatment 2008, 4:33-38
04 March 2008
Review
Quetiapine monotherapy for bipolar depression
Michael E Thase
Neuropsychiatric Disease and Treatment 2008, 4:21-31
04 March 2008
Review
Rasagiline in treatment of Parkinson’s disease
Lakshmi Nayak, Claire Henchcliffe
Neuropsychiatric Disease and Treatment 2008, 4:11-20
04 March 2008
Review
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
Angelo Antonini, Giovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, Leonardo Lopiano, et al
Neuropsychiatric Disease and Treatment 2008, 4:1-9
04 March 2008
Editorial Foreword: Drugs for Parkinson’s disease: Levodopa is still the gold standard || FREE PAPER ||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2008, 4:0-0
04 March 2008
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
